Edwin N Aroke1, Keesha L Powell-Roach2. 1. School of Nursing, University of Alabama at Birmingham, AL, USA. 2. 3463University of Florida, Gainesville, FL, USA.
Abstract
BACKGROUND: Chronic pain is a significant public health problem in the United States, affecting approximately 100 million people. Yet there is a lack of robust biomarkers for clinical use in chronic pain conditions. Downstream effects of environmental, genomic, and proteomic variations in individuals with chronic pain conditions can be identified and quantified using a metabolomic approach. AIM/ DESIGN: The purpose of this systematic review was to examine the literature for reports of potential metabolomic signatures associated with chronic pain conditions. METHODS: We searched relevant electronic databases for published studies that used various metabolomic approaches to investigate chronic pain conditions among subjects of all ages. RESULTS: Our search identified a total of 586 articles, 18 of which are included in this review. The reviewed studies used metabolomics to investigate fibromyalgia (n = 5), osteoarthritis (n = 4), migraine (n = 3), musculoskeletal pain (n = 2), and other chronic pain conditions (n = 1/condition). Results show that several known and newly identified metabolites differ in individuals with chronic pain conditions compared to those without these conditions. These include amino acids (e.g., glutamine, serine, and phenylalanine) and intermediate products (e.g., succinate, citrate, acetylcarnitine, and N-acetylornithine) of pathways that metabolize various macromolecules. CONCLUSION: Though more high-quality research is needed, this review provides insights into potential biomarkers for future metabolomics studies in people with chronic pain conditions.
BACKGROUND:Chronic pain is a significant public health problem in the United States, affecting approximately 100 million people. Yet there is a lack of robust biomarkers for clinical use in chronic pain conditions. Downstream effects of environmental, genomic, and proteomic variations in individuals with chronic pain conditions can be identified and quantified using a metabolomic approach. AIM/ DESIGN: The purpose of this systematic review was to examine the literature for reports of potential metabolomic signatures associated with chronic pain conditions. METHODS: We searched relevant electronic databases for published studies that used various metabolomic approaches to investigate chronic pain conditions among subjects of all ages. RESULTS: Our search identified a total of 586 articles, 18 of which are included in this review. The reviewed studies used metabolomics to investigate fibromyalgia (n = 5), osteoarthritis (n = 4), migraine (n = 3), musculoskeletal pain (n = 2), and other chronic pain conditions (n = 1/condition). Results show that several known and newly identified metabolites differ in individuals with chronic pain conditions compared to those without these conditions. These include amino acids (e.g., glutamine, serine, and phenylalanine) and intermediate products (e.g., succinate, citrate, acetylcarnitine, and N-acetylornithine) of pathways that metabolize various macromolecules. CONCLUSION: Though more high-quality research is needed, this review provides insights into potential biomarkers for future metabolomics studies in people with chronic pain conditions.
Authors: Irena Trbojević-Akmačić; Frano Vučković; Marija Vilaj; Andrea Skelin; Lennart C Karssen; Jasminka Krištić; Julija Jurić; Ana Momčilović; Jelena Šimunović; Massimo Mangino; Manuela De Gregori; Maurizio Marchesini; Concetta Dagostino; Jerko Štambuk; Mislav Novokmet; Richard Rauck; Yurii S Aulchenko; Dragan Primorac; Leonardo Kapural; Klaas Buyse; Dieter Mesotten; Frances M K Williams; Jan van Zundert; Massimo Allegri; Gordan Lauc Journal: Biochim Biophys Acta Gen Subj Date: 2018-07-05 Impact factor: 3.770
Authors: Bontle G Malatji; Shayne Mason; Lodewyk J Mienie; Ron A Wevers; Helgard Meyer; Mari van Reenen; Carolus J Reinecke Journal: Metabolomics Date: 2019-03-27 Impact factor: 4.290
Authors: Marta Guasch-Ferré; Adela Hruby; Estefanía Toledo; Clary B Clish; Miguel A Martínez-González; Jordi Salas-Salvadó; Frank B Hu Journal: Diabetes Care Date: 2016-05 Impact factor: 19.112
Authors: David Moher; Larissa Shamseer; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart Journal: Syst Rev Date: 2015-01-01
Authors: Bontle G Malatji; Helgard Meyer; Shayne Mason; Udo F H Engelke; Ron A Wevers; Mari van Reenen; Carolus J Reinecke Journal: BMC Neurol Date: 2017-05-11 Impact factor: 2.474